These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
420 related items for PubMed ID: 28229443
1. [Desvenlafaxine and neuropathic pain: additional clinical benefits of a second generation serotonin-noradrenaline reuptake inhibitor]. Alcantara-Montero A. Rev Neurol; 2017 Mar 01; 64(5):219-226. PubMed ID: 28229443 [Abstract] [Full Text] [Related]
3. Duloxetine versus other anti-depressive agents for depression. Cipriani A, Koesters M, Furukawa TA, Nosè M, Purgato M, Omori IM, Trespidi C, Barbui C. Cochrane Database Syst Rev; 2012 Oct 17; 10(10):CD006533. PubMed ID: 23076926 [Abstract] [Full Text] [Related]
4. Desvenlafaxine, a serotonin-norepinephrine uptake inhibitor for major depressive disorder, neuropathic pain and the vasomotor symptoms associated with menopause. Pae CU, Park MH, Marks DM, Han C, Patkar AA, Masand PS. Curr Opin Investig Drugs; 2009 Jan 17; 10(1):75-90. PubMed ID: 19127490 [Abstract] [Full Text] [Related]
5. Desvenlafaxine for major depressive disorder: incremental clinical benefits from a second-generation serotonin-norepinephrine reuptake inhibitor. Nichols AI, Tourian KA, Tse SY, Paul J. Expert Opin Drug Metab Toxicol; 2010 Dec 17; 6(12):1565-74. PubMed ID: 21067460 [Abstract] [Full Text] [Related]
6. Pharmacological treatments of neuropathic pain: The latest recommendations. Attal N. Rev Neurol (Paris); 2019 Dec 17; 175(1-2):46-50. PubMed ID: 30318260 [Abstract] [Full Text] [Related]
7. Role of vortioxetine in the treatment of neuropathic pain. Alcántara Montero A, Pacheco de Vasconcelos SR. Rev Esp Anestesiol Reanim (Engl Ed); 2022 Dec 17; 69(10):640-648. PubMed ID: 36241510 [Abstract] [Full Text] [Related]
8. Interactions between tamoxifen and antidepressants via cytochrome P450 2D6. Desmarais JE, Looper KJ. J Clin Psychiatry; 2009 Dec 17; 70(12):1688-97. PubMed ID: 20141708 [Abstract] [Full Text] [Related]
9. Pharmacological and clinical profile of newer antidepressants: implications for the treatment of elderly patients. Dolder C, Nelson M, Stump A. Drugs Aging; 2010 Aug 01; 27(8):625-40. PubMed ID: 20658791 [Abstract] [Full Text] [Related]
16. Desvenlafaxine succinate: a newer antidepressant for the treatment of depression and somatic symptoms. Seo HJ, Sohi MS, Patkar AA, Masand PS, Pae CU. Postgrad Med; 2010 Jan 01; 122(1):125-38. PubMed ID: 20107296 [Abstract] [Full Text] [Related]
17. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, Gilron I, Haanpää M, Hansson P, Jensen TS, Kamerman PR, Lund K, Moore A, Raja SN, Rice AS, Rowbotham M, Sena E, Siddall P, Smith BH, Wallace M. Lancet Neurol; 2015 Feb 01; 14(2):162-73. PubMed ID: 25575710 [Abstract] [Full Text] [Related]
19. Pharmacokinetic interactions of antidepressants. Richelson E. J Clin Psychiatry; 1998 Feb 01; 59 Suppl 10():22-6. PubMed ID: 9720479 [Abstract] [Full Text] [Related]
20. An integrated analysis of the efficacy and safety of desvenlafaxine in the treatment of major depressive disorder. Carrasco JL, Kornstein SG, McIntyre RS, Fayyad R, Prieto R, Salas M, Mackell J, Boucher M. Int Clin Psychopharmacol; 2016 May 01; 31(3):134-46. PubMed ID: 26895080 [Abstract] [Full Text] [Related] Page: [Next] [New Search]